Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EBITDA (2021 - 2025)

Tenon Medical (TNON) has 5 years of EBITDA data on record, last reported at -$3.3 million in Q3 2025.

  • For Q3 2025, EBITDA fell 4.87% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$12.8 million, up 5.93%, while the annual FY2024 figure was -$13.6 million, 12.24% up from the prior year.
  • EBITDA reached -$3.3 million in Q3 2025 per TNON's latest filing, down from -$2.8 million in the prior quarter.
  • Across five years, EBITDA topped out at -$200000.0 in Q1 2021 and bottomed at -$7.8 million in Q4 2022.
  • Average EBITDA over 5 years is -$3.4 million, with a median of -$3.2 million recorded in 2022.
  • Peak YoY movement for EBITDA: plummeted 1076.5% in 2022, then soared 60.72% in 2023.
  • A 5-year view of EBITDA shows it stood at -$2.8 million in 2021, then tumbled by 175.76% to -$7.8 million in 2022, then skyrocketed by 60.72% to -$3.1 million in 2023, then decreased by 0.29% to -$3.1 million in 2024, then dropped by 8.16% to -$3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$3.3 million in Q3 2025, -$2.8 million in Q2 2025, and -$3.6 million in Q1 2025.